Intelligent Ultrasound Group PLC (IUG:LSE) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Intelligent Ultrasound Group PLC stock forecast from 0 analysts, the average analyst target price for Intelligent Ultrasound Group PLC is not available over the next 12 months. Intelligent Ultrasound Group PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Intelligent Ultrasound Group PLC is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Intelligent Ultrasound Group PLC’s stock price was GBX 8.75. Intelligent Ultrasound Group PLC’s stock price has changed by -7.89% over the past week, -10.26% over the past month and -16.67% over the last year.
No recent analyst target price found for Intelligent Ultrasound Group PLC
No recent average analyst rating found for Intelligent Ultrasound Group PLC
Company Overview Intelligent Ultrasound Group PLC
Intelligent Ultrasound Group plc, through its subsidiaries, develops, markets, and distributes medical training simulators and clinical ultrasound software in the United Kingdom, North America, and internationally. It provides ScanNav Assist, an AI-based ultrasound software products that provide real-time image analysis during scanning in the women's health sector; and ScanNav Anatomy Peripheral Nerve Block (PNB), an AI based ultrasound software, which can automatically identify and highlight key anatomical structures in a live ultrasound scan. The company also offers ScanTrainer, an educational tool that uses real patient scans and curriculum based teaching across obstetrics, gynecology, general medicine, and emergency medicine; ScanNav Anatomy PNB Trainer to teach ultrasound-guided needling; BodyWorks Eve, an ultra-realistic female patient simulator designed to meet training needs of point of care ultrasound scenario; and NeedleTrainer, an augmented reality needling for non-invasive, safe, and realistic invasive guided needling training. In addition, it provides BabyWorks, a baby manikin training tool for point of care ultrasound and echocardiography in pediatric and neonatal care; HeartWorks, a highly realistic simulator with all the tools needed to learn echocardiography; BodyWorks, a hi-fidelity simulator used in critical care, intensive care, and emergency medicine; and ORSIM, a simulator designed to teach advanced bronchoscopy skills in a virtual environment. The company was formerly known as MedaPhor Group plc and changed its name to Intelligent Ultrasound Group plc in January 2019. Intelligent Ultrasound Group plc was founded in 2004 and is headquartered in Cardiff, the United Kingdom. Read Less
Intelligent Ultrasound Group plc, through its subsidiaries, develops, markets, and distributes medical training simulators and clinical ultrasound software in the United Kingdom, North America, and internationally. It provides ScanNav Assist, an AI-based ultrasound software produ...Read More
Frequently Asked Questions About Intelligent Ultrasound Group PLC (IUG:LSE) Stock
Stock Target Advisor's fundamental analysis for Intelligent Ultrasound Group PLC's stock is Slightly Bearish.
Unfortunately we do not have enough data on IUG:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on IUG:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on IUG:LSE's stock to indicate if its overvalued.
The last closing price of IUG:LSE's stock was GBX 8.75.
The most recent market capitalization for IUG:LSE is GBX 0.03B.
Unfortunately we do not have enough analyst data on IUG:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Intelligent Ultrasound Group PLC's stock.
As per our most recent records Intelligent Ultrasound Group PLC has 65 Employees.
Intelligent Ultrasound Group PLC's registered address is Hodge House, Cardiff, United Kingdom, CF10 1DY.
You can get more information about it from Intelligent Ultrasound Group PLC's website at https://www.intelligentultrasound.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IUG:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
